Elon Musk has reported the successful implantation of a Neuralink brain device in the inaugural human patient, noting the individual’s positive recovery one day post-surgery. This development marks a crucial step for Neuralink, a company dedicated to advancing brain-computer interfaces (BCI). Neuralink initiated its first clinical trial last year, receiving FDA approval and targeting individuals with quadriplegia due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for participation. The primary objective of Neuralink’s BCI is to empower individuals to control computer cursors or keyboards solely through their thoughts, addressing the needs of those with spinal cord injuries or ALS.
Read: Neuralink has installed its first brain chip into a human
In this week’s Tech Tuesday segment on Smile 90.4FM we discuss the first human trials of Neuralink and how the brain implant could change lives.
Listen down below.
